New Evidence from the Secondary Endpoints of the MADIT II Study
The landmark Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) demonstrated that the implantable defibrillator (ICD) improved survival in post-infarction patients with left ventricular ejection fractions of 30 or lower . Despite rigorous scrutiny, the study has resulted in acceptance of this recommendation by numerous regulatory agencies, both in the United States and Europe. MADIT II has been heralded as one of the most important research studies in cardiology in the past 20 years.
KeywordsLeft Ventricular Ejection Fraction Coronary Revascularization Implantable Defibrillator Multicenter Automatic Defibrillator Implantation Trial Heart Rate Turbulence
Unable to display preview. Download preview PDF.
- 2.Daubert JP, Zareba W, Schuger CD et al, for the MADIT II Investigators (2003) Does EPS inducibility in MADIT II patients predict subsequent VT and/or VF events? PACE 26:960Google Scholar
- 3.Reek S, Klein HU, Erdogan A et al, for the MADIT II Investigators (2003) Reproducibility of electrophysiological testing in patients with remote myocardial infarction and severe LV-dysfunction: MADIT II substudy. PACE 26:960Google Scholar
- 4.Greenberg HM, Case RB, Brown MW et al, for the MADIT II Investigators (2003) Mechanisms of mortality in the multicenter automatic defibrillator implantation trial (MADIT-II). PACE 26:961Google Scholar
- 6.Brodine WN, Tung RT, Lee JK et al (2003) Beta blocker use and appropriate ICD therapy in the MADIT-II study. PACE 26:961Google Scholar
- 7.Wilber DJ, Klein HU, Zareba W et al (2003) Does time from coronary revascularization influence the survival benefit of prophylactic implantable defibrillators in patients with impaired ventricular function following myocardial infarction? PACE 26:972Google Scholar
- 8.Wilber DJ, Zareba W, Hall WJ et al (2003) Time-dependence of mortality risk and defibrillator benefit following myocardial infarction: lessons from the multicenter automatic defibrillator implantation trial II. PACE 26:961Google Scholar
- 9.Zareba W, Steinberg J, Moss AJ et al, for MADIT II investigators (2003) Signal-averaged ECG and outcome in MADIT II patients. PACE 26:943Google Scholar
- 11.Berkowitsch A, Neumann T, Erdogan A et al (2003). Prognostic significance of heart rate turbulence and frequency of ventricular premature beats in MADIT II patients. PACE 26:1027Google Scholar
- 12.Haigney MC, Zareba W, Gentlesk P et al (2003) QT variability and appropriate ICD therapy in MADIT-II patients. PACE 26:942Google Scholar